A Practitioner's Guide to European Patent Law: For National Practice and the Unified Patent Court
Autor Paul Englanden Limba Engleză Hardback – 7 sep 2022
Preț: 1137.56 lei
Preț vechi: 1554.42 lei
-27% Nou
Puncte Express: 1706
Preț estimativ în valută:
217.70€ • 224.59$ • 184.25£
217.70€ • 224.59$ • 184.25£
Carte disponibilă
Livrare economică 12-26 februarie
Preluare comenzi: 021 569.72.76
Specificații
ISBN-13: 9781509947645
ISBN-10: 1509947647
Pagini: 664
Dimensiuni: 169 x 244 x 44 mm
Greutate: 1.25 kg
Ediția:2
Editura: Bloomsbury Publishing
Colecția Hart Publishing
Locul publicării:London, United Kingdom
ISBN-10: 1509947647
Pagini: 664
Dimensiuni: 169 x 244 x 44 mm
Greutate: 1.25 kg
Ediția:2
Editura: Bloomsbury Publishing
Colecția Hart Publishing
Locul publicării:London, United Kingdom
Caracteristici
Each chapter contains an outline of the common ground between the national approaches, as a guide for the possible application of European patent law in national courts and the UPC in the future
Notă biografică
Paul England is a solicitor at Taylor Wessing, London, UK.
Cuprins
Explanatory Note and AcknowledgementsAbbreviationsTable of CasesTable of EU and International Material Table of National MaterialsIntroductionI. Towards a ius commune of Patent LawII. The Purpose of this BookIII. Outline of Chapters1. The Skilled Person and their Common General KnowledgeI. The Skilled Person or TeamII. Common General KnowledgeIII. Towards Common Ground2. Construction and Scope of Protection of Patent ClaimsI. Statutory BasisII. Principles of constructionIII. General Principles of National Law on the Doctrine of EquivalentsIV. The Role of the "Formstein defence"V. The Role of the Prosecution FileVI. Particular terms and forms of claimVII. Forms of claimVIII. Numerical RangesIX. Towards Common Ground3. Direct InfringementI. Statutory BasisII. LiabilityIII. Product claims (Article 25(a) CPC 1989)IV. Process claims (Article 26 CPC 1989)V. Products Made by an Infringing Process (Article 24(c) CPC 1989)VI. Processes for obtaining new productsVII. Second Medical Use Claim InfringementVIII. Problems raised by purpose limited claimsIX. Infringement of DNA SequencesX. Unjustified threatsXI. Towards Common Ground4. Indirect InfringementI. Statutory BasisII. Means Relating to an Essential Element of the InventionIII. Means suitable for putting the invention into effectIV. Staple Commercial ProductsV. KnowledgeVI. Staple commercial productsVII. Double TerritorialityVIII. Extra-territorialityIX. Indirect Infringement of Second Medical Use ClaimsX. Other forms of contributory infringementXI. Towards Common Ground5. DefencesI. The Diverse Sources of Defence to InfringementII. The Experimental Use ExemptionIII. The Bolar ExemptionIV. Other defences in the CPC 1989V. ExhaustionVI. De minimisVII. Public interest compulsion and Crown useVIII. Invalidity and non-infringement of Claims AssertedIX. Euro-defencesX. Prior UseXI. Innocent Infringement as a Defence to DamagesXII. Towards Common Ground6. Declarations I. General jurisdictional basisII. Declarations of non-infringement III. Declaration that patent is standard essentialIV. Declarations concerning validity7. FRANDI. Standards, SEPs and FRANDII. European Guidance III. General Principles of National LawV. Determining the FRAND royalty rate8. RemediesI. Statutory BasisII. Preliminary InjunctionsIII. Damages for unjustified injunctionIV. Effect of Protective LetterV. Quia Timet InjunctionVI. Final InjunctionVII. Publication of JudgmentVIII. Affect of tested validityIX. Approach to costsX. Towards Common Ground9. Patentability and Industrial ApplicationI. Statutory BasisII. Industrial ApplicationIII. Excluded Subject-matterIV. Exceptions to PatentabilityV. Methods of Treatment and Diagnostics - Article 53(c) EPCVI. Towards Common Ground10. NoveltyI. Statutory BasisII. General Principles of EPO and National Case LawIII. Disclosure and enablementIV. Interpreting Patent Claims and the Prior Art for Novelty PurposesV. Made Available to the PublicVI. Novelty Over General Disclosures in the ArtVII. PriorityVIII. Product by Process ClaimsIX. First, Second and Subsequent Medical UsesX. Other Forms of Purpose-limited ClaimsXI. Claim AmendmentXII. Towards a Common Approach11. Inventive stepI. Statutory BasisII. DateIII. Determination of fact or law?IV. A technical or commercial question?V. The role of Common General KnowledgeVI. The Approach of the EPO BoardsVII. The Approaches of the National CourtsVIII. Criticism of Problem-and-SolutionIX. Criticism of Motivation-based TestsX. An Alternative Basis for Assessing Inventive StepXI. Mixed Technical and Non-technical FeaturesXII. Combinations of Prior Art FeaturesXIII. Other FactorsXIV. Towards Common Ground12. SufficiencyI. Statutory BasisII. General Approaches of EPO and National LawIII. Principle of general applicationIV. Forms of claimV. Inventive improvements / infringementsVI. Enablement not meeting quality promisedVII. ErrorsVIII. Biological DepositsIX. Plausibility in the Context of InsufficiencyX. Lack of ClarityXI. Towards Common Ground13. PlausibilityI. Is There a Statutory Basis?II. Origins of Plausibility in the EPOIII. Inventive StepIV. InsufficiencyV. Industrial ApplicabilityVI. The Novelty ContextVII. Post-dated EvidenceVIII. The Plausibility ThresholdIX. Further QuestionsX. Towards Common Ground14. Supplementary Protection CertificatesI. Statutory BasisII. Plant Protection RegulationIII. Conditions for GrantIV. Protected by a Basic Patent in ForceV. Marketing Authorisations in the SPC ContextVI. Extent of protection (Article 4 SPC Regulation)VII. Same Rights as Conferred by the Patent (Article 5 SPC Regulation)VIII. TermIX. Medicinal Products for Paediatric UseX. The SPC Manufacturing WaiverXI. Towards Common Ground15. Patent Ownership, Dealings and Employee InventorsI. IntroductionII. OwnershipIII. Inventor CompensationIV. Rights of Co-ownersV. Patent DealingsVI. Effect of Transfer of Ownership on LicenseeVII. Compulsory Licences and Licences of RightVIII. Public interest compulsion or Crown useIX. Patent Ownership, Dealings and Employee Inventors16. Cross-border Actions in Europe I. Relation between national and EPO proceedingsII. The Brussels RegulationIII. Cross-border Validity ActionsIV. Cross-border Infringement ActionsV. Cross-border Declarations of Non-infringementVI. Common Ground17. Evidence I. General principles II. Burden of proof III. General obligations to produce evidence IV. Specific procedures for obtaining evidence V. Witness of fact evidence VI. Expert opinion evidence VII. Evidence as Applied to Construction VIII. Experiments IX. Letters rogatory (letters of request) and US 1782 X. Border seizures XI. Confidentiality XII. PrivilegeAppendicesAppendix A: Extracts of EPC 2000Appendix B: Extracts of the Community Patent Convention 1989Appendix C: The SPC RegulationAppendix D: The Biotechnology DirectiveAppendix E: The Enforcement DirectiveAppendix F: The Unitary Patent RegulationAppendix G: Extracts of the Unified Patent Court AgreementAppendix H: Consolidated Version of the Paediatric RegulationIndex